Do HIV treatment eligibility expansions crowd out the sickest?: Evidence from rural South Africa
The 2015 WHO recommendation to initiate all HIV patients on antiretroviral therapy (ART) at diagnosis could potentially overextend health systems and crowd out sicker patients, mitigating the policy's impact. We evaluate whether South Africa's prior eligibility expansion from CD4 ≤ 200 to...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
27 June 2018
|
| In: |
Tropical medicine & international health
Year: 2018, Volume: 23, Issue: 9, Pages: 968-979 |
| ISSN: | 1365-3156 |
| DOI: | 10.1111/tmi.13122 |
| Online Access: | Resolving-System, Volltext: https://doi.org/10.1111/tmi.13122 Verlag: https://onlinelibrary.wiley.com/doi/abs/10.1111/tmi.13122 
|
| Author Notes: | Sheryl A. Kluberg, Matthew P. Fox, Michael LaValley, Deenan Pillay, Till Bärnighausen and Jacob Bor |
| Summary: | The 2015 WHO recommendation to initiate all HIV patients on antiretroviral therapy (ART) at diagnosis could potentially overextend health systems and crowd out sicker patients, mitigating the policy's impact. We evaluate whether South Africa's prior eligibility expansion from CD4 ≤ 200 to CD4 ≤ 350 cells/μl reduced ART uptake in the sickest patients. |
|---|---|
| Item Description: | Gesehen am 18.11.2019 |
| Physical Description: | Online Resource |
| ISSN: | 1365-3156 |
| DOI: | 10.1111/tmi.13122 |